Immunotherapy with Interleukin-2: A Study Based on Mathematical Modeling

Adam J. and N. Bellomo E. (1997). A Survey Models for Tumor-Immune System Dynamics, Birkhäuser, Boston, MA.10.1007/978-0-8176-8119-7Search in Google Scholar

Banerjee S. and Sarkar R. R. (2008). Delay induced model for tumor-immune interaction and control of malignant tumor growth, Biosciences91(1): 268-288.10.1016/j.biosystems.2007.10.002Search in Google Scholar

Bodnar M. and Foryś U. (2000a). Behaviour of solutions to Marchuk's model depending on a time delay, International Journal of Applied Mathematics and Computer Science10(1): 97-112.Search in Google Scholar

Bodnar M. and Foryś U. (2000b). Periodic dynamics in the model of immune system, International Journal of Applied Mathematics and Computer Science10(1): 113-126.10.4064/am-27-1-113-126Search in Google Scholar

Bodnar M. and Foryś U. (2003a). Time delays in proliferation process for solid avascular tumor, Mathematical and Computer Modeling37(11): 1201-1209.10.1016/S0895-7177(03)80019-5Search in Google Scholar

Bodnar M. and Foryś U. (2003b). Time delays in regulatory apoptosis for solid avascular tumor, Mathematical and Computer Modeling37(11): 1211-1220.10.1016/S0895-7177(03)00131-6Search in Google Scholar

Byrne H. M. (1997). The effect of time delays on the dynamics of avascular tumor growth, Mathematical Biosciences144(2): 83-117.10.1016/S0025-5564(97)00023-0Search in Google Scholar

Curti B. D., Ochoa A. C., Urba W. J., Alvord W. G., Kopp W. C., Powers G., Hawk C., Creekmore S. P., Gause B. L., Janik J. E., Holmlund J. T., Kremers P., Fenton R. G., Miller L., Sznol M., II J. W. S., Sharfman W. H. and Longo D. L. (1996). Influence of interleukin-2 regimens on circulating populations of lymphocytes after adoptive transfer of anticd3-stimulated t cells: Results from a phase i trial in cancer patients, Journal of Immunotherapy19(4): 296-308.10.1097/00002371-199607000-00005Search in Google Scholar

Foryś U. (2002). Marchuk's model of immune system dynamics with application to tumor growth, Journal of Theoretical Medicine4(1): 85-93.10.1080/10273660290052151Search in Google Scholar

Freedman H. I., Erbe L. and Rao V. S. H. (1986). Three species food chain models with mutual interference and time delays, Mathematical Biosciences80(1): 57-80.10.1016/0025-5564(86)90067-2Search in Google Scholar

Freedman H. I. and Rao V. S. H. (1983). The trade-off between mutual interference and time lags in predator-prey systems, Bulletin of Mathematical Biology45(6): 991-1004.10.1016/S0092-8240(83)80073-1Search in Google Scholar

Galach M. (2003). Dynamics of the tumor-immune system competition-the effect of time delay, International Journal of Applied Mathematics and Computer Science13(3): 395-406.Search in Google Scholar

Gause B. L., Sznol M., Kopp W. C., Janik J. E., II J. W. S., Steis R. G., Urba W. J., Sharfman W., Fenton R. G., Creekmore S. P., Holmlund J., Conlon K. C., VanderMolen L. A. and Longo D. L. (1996). Phase i study of subcutaneously administered interleuking-2 in combination with interferon alfa-2a in patients with advanced cancer, Journal of Clinical Oncology14(8): 2234-2241.10.1200/JCO.1996.14.8.2234Search in Google Scholar

Hale J. and Lunel S. (1993). Introduction to Functional Differential Equations, Springer-Verlag, New York, NY.10.1007/978-1-4612-4342-7Search in Google Scholar

Hara I., Hotta H., Sato N., Eto H., Arakawa S. and Kamidono S. (1996). Rejection of mouse renal cell carcinoma elicited by local secretion of interleukin-2, Japanese Journal of Cancer Research87(7): 724-729.10.1111/j.1349-7006.1996.tb00284.xSearch in Google Scholar

Kaempfer R., Gerez L., Farbstein H., Madar L., Hirschman O., Nussinovich R. and Shapiro A. (1996). Prediction of response to treatment in superficial bladder carcinoma through pattern of interleukin-2 gene expression, Journal of Clinical Oncology14(6): 1778-1786.10.1200/JCO.1996.14.6.1778Search in Google Scholar

Keilholz U., Scheibenbogen C., Stoelben E., Saeger H. D. and Hunstein W. (1994). Immunotherapy of metastatic melanoma with interferon-alpha and interleukin-2: Pattern of progression in responders and patients with stable disease with or without resection of residual lesions, European Journal of Cancer30A(7): 955-958.10.1016/0959-8049(94)90122-8Search in Google Scholar

Kirschner D. and Panetta J. C. (1998). Modeling immunotherapy of the tumor — immune interaction, Journal of Mathematical Biology37(3): 235-252.10.1007/s002850050127Search in Google Scholar

Kolev M. (2003). Mathematical modeling of the competition between acquired immunity and cancer, International Journal of Applied Mathematics and Computer Science13(3): 289-296.Search in Google Scholar

Kuznetsov V. A., Makalkin I. A., Taylor M. A. and Perelson A. S. (1994). Nonlinear dynamics of immunogenic tumors: parameter estimation and global bifurcation analysis, Bulletin of Mathematical Biology56(2): 295-321.10.1016/S0092-8240(05)80260-5Search in Google Scholar

Matzavinos A., A. J. Chaplain M. and Kuznetsov V. A. (2004). Mathematical modelling of the spatio-temporal response of cytotoxic t-lymphocytes to a solid tumor, Mathematical Medicine and Biology21(1): 1-34.10.1093/imammb/21.1.115065736Search in Google Scholar

Rabinowich H., Banks M., Reichert T. E., Logan T. F., Kirkwood J. M. and Whiteside T. L. (1996). Expression and activity of signaling molecules in t-lymphocytes obtained from patients with metastatic melanoma before and after interleukin-2 therapy, Clinical Cancer Research2(8): 1263-1274.Search in Google Scholar

Rosenberg S. A. and Lotze M. T. (1986). Cancer immunotherapy using interleukin-2 and interleukin-2-activated lymphocytes, Annual Review of Immunology4(1): 681-709.10.1146/annurev.iy.04.040186.0033413518753Search in Google Scholar

Rosenberg S. A., Yang J. C., Topalian S. L., Schwartzentruber D. J., Weber J. S., Parkinson D. R., Seipp C. A., Einhorn J. H. and White D. E. (1994). Treatment of 283 consecutive patients with metastatic melanoma or renal cell cancer using high-dose bolus interleukin 2, Journal of the American Medical Association271(12): 907-913.10.1001/jama.271.12.907Search in Google Scholar

Rosenstein M., Ettinghousen S. E. and Rosenberg S. A. (1986). Extravasion of intravascular fluid mediated by the systemic administration of recombinant interleukin-2, Journal of Immunology137(5): 1735-1742.10.4049/jimmunol.137.5.1735Search in Google Scholar

Sarkar R. R. and Banerjee S. (2005). Cancer self remission and tumor stability — A stochastic approach, Mathematical Biosciences196(1): 65-81.10.1016/j.mbs.2005.04.001Search in Google Scholar

Schwartzentruber D. J. (1993). In vitro predictors of clinical response in patients receiving interleukin-2-based immunotherapy, Current Opinion in Oncology5(6): 1055-1058.10.1097/00001622-199311000-00018Search in Google Scholar

Szymańska Z. (2003). Analysis of immunotherapy models in the context of cancer dynamics, International Journal of Applied Mathematics and Computer Science13(3): 407-418.Search in Google Scholar

Tartour E., Blay J. Y., Dorval T., Escudier B., Mosseri V., Douillard J. Y., Deneux L., Gorin I., Negrier S., Mathio C., Pouillart P. and Fridman W. H. (1996). Predictors of clinical response to interleukin-2-based immunotherapy in melanoma patients: A French multi-institutional study, Journal of Clinical Oncology14(5): 1697-1703.10.1200/JCO.1996.14.5.1697Search in Google Scholar

Yang X., Chen L. and Chen J. (1996). Permanence and positive periodic solution for the single-species nonautonomous delay diffusive model, Computers and Mathematics with Applications32(4): 109-116.10.1016/0898-1221(96)00129-0Search in Google Scholar

Zhivkovc P. and Waniewski J. (2003). Modeling tumor-immunity interactions with different stimulation functions, International Journal of Applied Mathematics and Computer Science13(3): 307-315.Search in Google Scholar